These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 11705126

  • 21. Pharmacological treatment of depression with and without headache disorders: an appraisal of cost effectiveness and cost utility of antidepressants.
    Pan YJ, Kuo KH, Wang SJ.
    J Affect Disord; 2015 Jan 01; 170():255-65. PubMed ID: 25261631
    [Abstract] [Full Text] [Related]

  • 22. Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysis.
    Sclar DA, Skaer TL, Robison LM, Galin RS, Legg RF, Nemec NL.
    J Clin Psychiatry; 1998 Jan 01; 59 Suppl 2():13-7. PubMed ID: 9559755
    [Abstract] [Full Text] [Related]

  • 23. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy.
    Wade RL, Kindermann SL, Hou Q, Thase ME.
    J Manag Care Pharm; 2014 Jan 01; 20(1):76-85. PubMed ID: 24372461
    [Abstract] [Full Text] [Related]

  • 24. Cost-benefit analysis of newer versus older antidepressants--pharmacoeconomic studies comparing SSRIs/SNRIs with tricyclic antidepressants.
    Laux G.
    Pharmacopsychiatry; 2001 Jan 01; 34(1):1-5. PubMed ID: 11229615
    [Abstract] [Full Text] [Related]

  • 25. Pharmacoeconomic analysis of venlafaxine in the treatment of major depressive disorder.
    Einarson TR, Addis A, Iskedjian M.
    Pharmacoeconomics; 1997 Aug 01; 12(2 Pt 2):286-96. PubMed ID: 10170453
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
    Croft H, Settle E, Houser T, Batey SR, Donahue RM, Ascher JA.
    Clin Ther; 1999 Apr 01; 21(4):643-58. PubMed ID: 10363731
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts.
    Berndt ER, Bhattacharjya A, Mishol DN, Arcelus A, Lasky T.
    J Ment Health Policy Econ; 2002 Mar 01; 5(1):3-19. PubMed ID: 12529566
    [Abstract] [Full Text] [Related]

  • 33. The pharmacoeconomics of venlafaxine in depression.
    Morrow TJ.
    Am J Manag Care; 2001 Sep 01; 7(11 Suppl):S386-92. PubMed ID: 11570029
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Health resource use and costs of vilazodone and other selective serotonin re-uptake inhibitors in treating major depressive disorder.
    Zhou ZY, Sun S, Chopra P, Zhong Y, Totev T, Signorovitch J.
    J Med Econ; 2015 Sep 01; 18(11):919-29. PubMed ID: 26121061
    [Abstract] [Full Text] [Related]

  • 37. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C.
    Cochrane Database Syst Rev; 2013 Jul 17; 2013(7):CD004185. PubMed ID: 24353997
    [Abstract] [Full Text] [Related]

  • 38. Increased rate of trazodone prescribing with bupropion and selective serotonin-reuptake inhibitors versus tricyclic antidepressants.
    Clark NA, Alexander B.
    Ann Pharmacother; 2000 Sep 17; 34(9):1007-12. PubMed ID: 10981245
    [Abstract] [Full Text] [Related]

  • 39. Evaluating the economic consequences of early antidepressant treatment discontinuation: a comparison between controlled-release and immediate-release paroxetine.
    Sheehan DV, Eaddy M, Sarnes M, Vishalpura T, Regan T.
    J Clin Psychopharmacol; 2004 Oct 17; 24(5):544-8. PubMed ID: 15349013
    [Abstract] [Full Text] [Related]

  • 40. Effect of antidepressant choice on the incidence and economic intensity of hospitalization among depressed individuals.
    Croghan TW, Kniesner TJ, Melfi CA, Robinson RL.
    Adm Policy Ment Health; 2000 Mar 17; 27(4):183-95. PubMed ID: 10911668
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.